EMILY LACEK: Open Payments
NPI 1770033979 · DARBY, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,290 in 66 payments from 12 companies in 2025. Trend: 2023 $1,509 · 2024 $1,753 · 2025 $1,290
Food & beverage: $1,290
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $310 |
| Ardelyx, Inc. | 7 | $196 |
| Madrigal Pharmaceuticals | 13 | $172 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $155 |
| Janssen Biotech, Inc. | 1 | $116 |
| Aimmune Therapeutics, Inc. | 4 | $76 |
| QOL Medical, LLC | 4 | $63 |
| Lilly USA, LLC | 3 | $55 |
| PFIZER INC. | 3 | $54 |
| Braintree Laboratories, Inc. | 2 | $40 |
Products named: IBSRELA, REZDIFFRA, CREON, XIFAXAN, TREMFYA, ZENPEP, Sucraid, RINVOQ.
Industry payments across PA — which companies pay providers there.
